Bivalirudin in acute coronary syndromes

被引：0
|
作者：
Sanmartin, Marcelo [1 ]
机构：
[1] Hosp Meixoeiro, Vigo 36200, Spain
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1069 / 1070
页数：2
相关论文
共 50 条
  • [31] Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
    Farag, Mohamed
    Gorog, Diana A.
    Prasad, Abhiram
    Srinivasan, Manivannan
    OPEN HEART, 2015, 2 (01):
  • [32] Outcomes of bivalirudin in moderate and high risk patients with acute coronary syndromes and renal insufficiency: An ACUITY substudy
    Kirtane, Aiay J.
    Mehran, Roxana
    Dangas, George
    Manoukian, Steven
    Feit, Frederick
    Stuckey, Thomas
    Ohman, Magnus
    Hamon, Martial
    Cequier, Angel
    Cohen, David
    Pollack, Charles
    Hoekstra, James
    Pocock, Stuart
    Gersh, Bernard
    Stella, Joseph
    Bertrand, Michel
    Desmet, Walter
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 4B - 5B
  • [33] New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?
    Asuncion Esteve-Pastor, Maria
    Hernandez-Romero, Diana
    Valdes, Mariano
    Marin, Francisco
    MOLECULES, 2016, 21 (03):
  • [34] Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
    Verdoi, Monica
    Schaffer, Alon
    Barbieri, Lucia
    Suryapranata, Harry
    De Luca, Giuseppe
    REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (08): : 732 - 745
  • [35] Bivalirudin during early invasive strategy for acute coronary syndromes: Noninferiority in ACUITY lies in the eyes of the beholder
    Kaul, Sanjay
    Shah, Prediman K.
    Diamond, George A.
    CIRCULATION, 2006, 114 (18) : 552 - 552
  • [36] Acute coronary syndromes or acute frailty syndromes?
    Ambrosetti, Marco
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (17) : 1811 - 1812
  • [37] Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
    Nuehrenberg, Thomas G.
    Hochholzer, Willibald
    Mashayekhi, Kambis
    Ferenc, Miroslaw
    Neumann, Franz-Josef
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (09) : 807 - 815
  • [38] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN: DIFFERENTIAL BENEFIT ACROSS THE SPECTRUM OF PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A118 - A118
  • [39] Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: Have we discarded bivalirudin too soon?
    Benenati, Stefano
    Maria, Giovanni Luigi De
    Della Mora, Francesco
    Portolan, Leonardo
    Kotronias, Rafail
    Kharbanda, Rajesh K.
    Porto, Italo
    Banning, Adrian P.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 57 : 70 - 79
  • [40] Efficacy and Safety of Bivalirudin in Patients Receiving Clopidogrel Therapy After Diagnostic Angiography for Percutaneous Coronary Intervention in Acute Coronary Syndromes
    Feldman, Dmitriy N.
    Minutello, Robert M.
    Bergman, Geoffrey
    Moussa, Issam
    Wong, S. Chiu
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (04) : 513 - 524
12345